Canagliflozin Alternatives in Louisiana
Compare generic and therapeutic alternatives to Canagliflozin (canagliflozin) available at Louisiana pharmacies. Save up to 48% on your prescription — no insurance required.
Top Alternatives in Louisiana
Metformin
therapeutic
First-line T2D medication — dramatically cheaper
Avg cash price: $8/mo
Dapagliflozin (Farxiga)
therapeutic
Competing SGLT2 inhibitor with similar profile
Avg cash price: $530/mo
Empagliflozin (Jardiance)
therapeutic
SGLT2 inhibitor with strong cardiovascular outcomes data
Avg cash price: $560/mo
Louisiana Prescription Assistance Programs
Louisiana Medicaid Rx
Prescription drug coverage for Louisiana Medicaid beneficiaries through the managed care program.
Eligibility: Low-income Louisiana adults up to 138% FPL (post-expansion), plus children and pregnant women at higher thresholds.
Louisiana Senior Rx Assistance
State-administered program connecting low-income seniors to pharmaceutical manufacturer assistance programs and Medicare Extra Help.
Eligibility: Louisiana seniors aged 60+ who are Medicare beneficiaries with income below 135% FPL.
Frequently Asked Questions
Is there a generic for canagliflozin (Invokana)?
Not yet as of 2025. Canagliflozin is still under brand exclusivity as Invokana. All SGLT2 inhibitors remain brand-only at similar high prices.
How does canagliflozin compare to other SGLT2 inhibitors?
Canagliflozin, dapagliflozin, and empagliflozin have similar glucose-lowering effects. Differences emerge in cardiovascular and renal outcomes data — your cardiologist or endocrinologist guides the choice.
What is the main risk specific to canagliflozin?
Canagliflozin carries an FDA warning about increased risk of lower-limb amputations, particularly in patients with peripheral vascular disease. Discuss your individual risk with your doctor.
Can Script Unlock help with canagliflozin costs?
While there is no generic, Script Unlock pharmacies sometimes offer lower cash-pay brand pricing. It is worth posting your script to compare bids.
Is metformin a good alternative to canagliflozin for T2D?
Metformin is first-line T2D therapy at under $10/month. SGLT2 inhibitors like canagliflozin are added for patients who need additional cardiovascular or renal benefits beyond glucose lowering.